Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 1997

View Archived Issues

New antioxidants from Shiseido

Natural products for the treatment of BPH

MS&D reveals nonpeptide tachykinin antagonists

Metabotropic glutamate receptor modulators from Lilly

SmithKline Beecham focuses on hemoregulatory compounds

MMP and TNF production inhibitors described by DuPont Merck

Lilly reports new salt of PKC inhibitor with improved pharmaceutical properties

Mirapex now available in U.S.

Didronel PMO now available for expanded use in the U.K.

Losec available in U.K. for symptoms of dyspepsia

Dovonex cleared for use in children in the U.K.

Novel antitumor agents from Sanwa Kagaku

DuPont Merck investigates new approach to potent HIV protease inhibitors

Low-dose combination of ramipril and felodipine evaluated in SHR

JL-13 possesses atypical antipsychotic profile

ChiRex to purchase Glaxo Wellcome manufacturing site

Inositol for psychiatric disorders

Transcell and Merck & Co. collaborate on antibacterial research

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

Transdermal xanomeline in development for Alzheimer's disease

MGI Pharma launches INFeD for anemia in cancer patients

Immunex receives approval to market paclitaxel in Canada

NKH-477 possesses antidepressant effects

Perospirone vs. mosapramine for schizophrenia

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

Promising preliminary results from open trial of lamotrigine in depression

Jenner Technologies reports results from phase I/II trial of prostate cancer vaccine

ABS and Chinese Academy of Medical Science expand alliance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...